Lupin and Avas Launch NaMuscla® in Italy Enables expanded access to the only EU-approved treatment for the myotonia symptoms ...

Mumbai: Global pharma major Lupin Limited and Avas Pharmaceuticals SRL have announced the launch of Lupin's orphan drug ...

Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug ...

Lupin and Avas Launch NaMuscla® in Italy Enables expanded access to the only EU-approved treatment for the myotonia symptoms in adults with non-dystrophic myotonic disorders Mumbai, Zug, January ...

Lupin and Avas launch NaMuscla in Italy to treat myotonia in adults with NDM disorders: Our Bureau, Mumbai Tuesday, January 28, 2025, 16:45 Hrs [IST] Global pharma major Lupin Lim ...

Lupin receives US FDA approval for generic Atrovent nasal spray, 0.06%: Our Bureau,Mumbai Tuesday, January 28, 2025, 17:30 Hrs [IST] Global pharma major Lupin Limited (Lupin) anno ...

Experts at the e4m India Brand Conclave 2025 emphasised brand identity, storytelling, and strategic platform selection for ...

As she recounted some of the experiences, Doreen Nambuya Guloba struggled to hold back tears."One day, I remember when we rescued a girl from Kasangati who had been gang raped; we had to go with an ...

Netflix is doubling down on global talent in 2025, with some eye-catching projects from Europe and the Americas.

As of 9:22:36 AM GMT+5:30. Market Open.